Eticovo — Medical Mutual
Behcet’s Disease
Initial criteria
- Patient age ≥ 2 years
- Patient has tried at least one conventional therapy (corticosteroids, immunosuppressants, interferon alfa) OR has already had trial of one biologic other than requested drug
- Medication prescribed by or in consultation with rheumatologist, dermatologist, ophthalmologist, gastroenterologist, or neurologist
- Site of care medical necessity is met
Reauthorization criteria
- Patient established on etanercept therapy ≥ 3 months
- Beneficial clinical response on objective measures (e.g., visual acuity, serum markers, ulcer/lesion size)
- Improvement in at least one symptom (e.g., decreased pain, improved acuity)
- Site of care medical necessity is met
Approval duration
initial 3 months, reauth 1 year